… supervision of an anaesthetist (a doctor specialised in anaesthesia). Sugammadex Fresenius … package leaflet or contact your doctor or pharmacist. How does Sugammadex … carried out with the reference medicine, Bridion, and do not need to …

… to include coronary spasm. Bridion labeling   Bydureon (exenatide …   Counseling Information,” and “Medication Guide,”  sections of the … Methylphenidate Methylphenidate hydrochloride Drug interaction between CNS … Example: Inlyta labeling FDA determined that no …

… vaccine, was also recommended for the prevention of COVID-19. Orphan drugs … for several drugs, including Ofev for the treatment of … children and adolescents, Blincyto, Bridion, Flucelvax Tetra, Jemperli, Omvoh … the Committee for Medicinal Products for Human …

… a self-amplifying mRNA vaccine intended for the prevention … clinical tests and clinical trials of an already … six biosimilar medicines: Avtozma (tocilizumab), for the treatment of rheumatoid … medicines that are already authorised in the EU: Blincyto*, Bridion …

… the marketing authorisation for the medicinal product Bridion. The marketing authorisation holder … for this medicinal product is Merck … information, the full indications for Bridion will be as follows: Reversal …

… supervision of an anaesthetist (a doctor specialised in anaesthesia). Sugammadex Amomed … package leaflet or contact your doctor or pharmacist. How does Sugammadex … carried out with the reference medicine, Bridion, and do not need to …

… the active ingredient of BRIDION®. Merck applied for FDA approval of sugammadex … ,” stating: [T]he purpose of [§ 156] is clear: to compensate pharmaceutical companies … for regulatory approval of new drug applications. With this purpose in …

… ingredient in Merck's Bridion drug, which is used to … for the delay in obtaining FDA approval," citing Merck … intent to "compensate pharmaceutical companies for the effective truncation … " (emphasis added) (stating this is "the most …

… related to Merck’s Bridion®, a drug with the active ingredient … to the Food and Drug Administration (“FDA”) for approval of … cases were consolidated. At trial, Aurobindo argued that based … Act: “to compensate the pharmaceutical companies for the effective …

… appealed to the Patent Trial and Appeal Board, and … specification did not limit the treatment to any specific disease, … ingredient in Merck’s drug BRIDION®. Merck then filed a … View Opinion  Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc., et al …